<DOC>
	<DOCNO>NCT00235066</DOCNO>
	<brief_summary>The main objective study ass effectiveness CYPHER™ ( sirolimus-eluting ) stent reduce in-lesion late lumen loss de novo native coronary artery lesion small vessel ( 2.25 - 2.75 mm ) compare small vessel tercile uncoated Bx VELOCITYTM Stent patient SIRIUS Trial , use stenting technique minimizes balloon trauma vessel assure full coverage lesion stent .</brief_summary>
	<brief_title>The CYPHER™ Stent Study Patients With Small de Novo Coronary Artery Lesions .</brief_title>
	<detailed_description>This international , multicenter ( 10 site ) , nonrandomized , historically control study patient De Novo coronary artery lesion small vessel treat CYPHER™ ( sirolimus-eluting ) stent compare small vessel tercile uncoated Bx VELOCITYTM Stent patient SIRIUS Trial . A total 100 patient enrol study . Patients de novo native coronary artery lesion &gt; =15mm &lt; =30mm length &gt; =2.25 mm &lt; =2.75 mm diameter visual estimation treat CYPHER™ ( sirolimus-eluting ) stent . Patients follow 30 day , 6 , 8 , 9 month 1 , 2 3 year post-procedure , repeat angiography 8 month . In patient Intravascular Ultrasound ( IVUS ) perform ( case cross success ) initial procedure . An IVUS control also do 8 month follow assess neo-intimal growth remodel . This single lesion treatment study . Patients may lesions treated treatment intend lesion small vessel ( non-target lesion may locate target vessel ! ) . Post-procedural treatment another lesion allow 30-day follow-up contact complete case clinically need . It anticipate total length study 39 month : 3 month complete patient enrollment 3 year follow-up .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>1 . Diagnosis angina pectoris define Canadian Cardiovascular Society Classification ( CCS 1 , 2 , 3 , 4 ) OR unstable angina pectoris ( Braunwald Classification B &amp; C 12 ) OR patient document silent ischemia ; 2 . Single treatment de novo lesion small vessel ( 2.25 2.75 mm ) major coronary artery patient single multivessel disease . Patients multiple lesion include lesion successfully treat prior treatment intend lesion small vessel . 3 . Target vessel diameter &gt; =2.25 &lt; =2.75mm ( visual estimation ) ; 4 . Target lesion length &gt; =15 &lt; =30 mm . 1 . Patient experience Qwave nonQwave myocardial infarction document total CK &gt; 2 time normal within precede 24 hour CK CKMB remain normal time treatment ; 2 . Has unstable angina classify Braunwald A ( 1 , 2 , 3 ) B &amp; C 3 ; 3 . Unprotected leave main coronary disease &gt; =50 % stenosis ; 4 . Significant ( &gt; 50 % ) stenosis proximal distal target lesion might require revascularization impede inflow runoff ; 5 . Have ostial target lesion ; 6 . Lesion &lt; 2.25 &gt; 2.75 mm diameter ; 7 . Totally occluded vessel ( TIMI 0 level ) ; 8 . Documented leave ventricular ejection fraction £30 % ; 9 . Intention treat target lesion direct stenting procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
</DOC>